Moberg Pharma AB (MBGPF)
1.10
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Moberg Pharma Total Liabilities (Quarterly) : 1.926M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.926M |
| December 31, 2025 | 1.849M |
| September 30, 2025 | 1.781M |
| June 30, 2025 | 3.11M |
| March 31, 2025 | 1.732M |
| December 31, 2024 | 1.744M |
| September 30, 2024 | 1.640M |
| June 30, 2024 | 2.884M |
| March 31, 2024 | 2.542M |
| December 31, 2023 | 2.382M |
| September 30, 2023 | 2.524M |
| June 30, 2023 | 2.218M |
| March 31, 2023 | 2.142M |
| December 31, 2022 | 2.960M |
| September 30, 2022 | 1.230M |
| June 30, 2022 | 1.512M |
| March 31, 2022 | 1.508M |
| December 31, 2021 | 1.860M |
| September 30, 2021 | 1.809M |
| June 30, 2021 | 1.800M |
| March 31, 2021 | 2.075M |
| December 31, 2020 | 10.35M |
| September 30, 2020 | 3.535M |
| June 30, 2020 | 3.842M |
| March 31, 2020 | 3.699M |
| Date | Value |
|---|---|
| June 30, 2019 | 9.586M |
| March 31, 2019 | 82.50M |
| December 31, 2018 | 74.17M |
| September 30, 2018 | |
| June 30, 2018 | 76.58M |
| March 31, 2018 | 78.88M |
| December 31, 2017 | 81.94M |
| September 30, 2017 | 80.30M |
| June 30, 2017 | 80.15M |
| March 31, 2017 | 75.26M |
| December 31, 2016 | 73.81M |
| September 30, 2016 | 51.18M |
| June 30, 2016 | 40.78M |
| March 31, 2016 | 42.45M |
| December 31, 2015 | 5.294M |
| September 30, 2015 | 7.104M |
| June 30, 2015 | 10.35M |
| March 31, 2015 | 8.169M |
| December 31, 2014 | 7.150M |
| September 30, 2014 | 8.273M |
| June 30, 2014 | 12.99M |
| March 31, 2014 | 11.48M |
| December 31, 2013 | 10.92M |
| September 30, 2013 | 11.69M |
| June 30, 2013 | 13.10M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Orexo AB | 25.78M |
| Swedencare AB | 295.65M |
| Camurus AB | 56.25M |
| Infant Bacterial Therapeutics AB | 6.354M |
| AstraZeneca PLC | 66.63B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 71.75M |
| Shareholders Equity (Quarterly) | 69.82M |
| Debt to Equity Ratio | 0.0032 |
| Current Ratio | 13.12 |
| Net Debt Paydown Yield | 0.06% |